In the latest trading session, AbbVie closed at $187.12, marking a +1.23% move from the previous day, outperforming the S&P ...

Shares of AbbVie Inc. ABBV advanced 1.22% to $187.11 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,309.62 and the ...

A federal jury in Delaware found that Revance's rival product infringed patents for Allergan's market-leading neurotoxin ...

AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...

AbbVie's dividends add to its attractiveness at an uncertain time, adding to robust price returns over time. Click here to ...

AbbVie (ABBV) faced a tough market day on July 21, 2025, as their stock price dropped by 2.33%, marking a two-day total decline of 3.42%. This significant trading volume of 9.22 billion ranked them ...

This was the stock's second consecutive day of losses.

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million.

A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...

AbbVie Inc. (NYSE:ABBV) stands out as a major player in the pharmaceutical industry, with a broad range of approved ...

AbbVie Inc. (NYSE: ABBV) is one of the high-margin pharma stocks to buy now . AbbVie Inc. (NYSE:ABBV) received a slight boost ...

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...